WO1996006655A1 - Low profile defibrillation catheter - Google Patents

Low profile defibrillation catheter Download PDF

Info

Publication number
WO1996006655A1
WO1996006655A1 PCT/US1995/010926 US9510926W WO9606655A1 WO 1996006655 A1 WO1996006655 A1 WO 1996006655A1 US 9510926 W US9510926 W US 9510926W WO 9606655 A1 WO9606655 A1 WO 9606655A1
Authority
WO
WIPO (PCT)
Prior art keywords
electrode
catheter
defibrillation
coil
low profile
Prior art date
Application number
PCT/US1995/010926
Other languages
French (fr)
Inventor
Kenneth M. Anderson
Mark W. Kroll
Original Assignee
Angeion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeion Corporation filed Critical Angeion Corporation
Priority to AU36252/95A priority Critical patent/AU3625295A/en
Publication of WO1996006655A1 publication Critical patent/WO1996006655A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/0563Transvascular endocardial electrode systems specially adapted for defibrillation or cardioversion

Definitions

  • the present invention pertains to a defibrillation device and, more particularly, refers to a low profile defibrillation catheter where at least one of the current conductors is utilized as a defibrillation electrode.
  • the implantable defibrillator requires the use of electrodes to conduct large currents through the human heart. Previously, these electrodes have typically been two or more patches stitched to the heart. These are referred to as epicardial-patch electrodes and require the surgeon to open the chest cavity for placement.
  • electrode coils are sometimes inserted into the heart chambers via venous routes using various procedures known within the medical and surgical arts.
  • a vein such as the subclavian vein, the right or left cephalic vein or the internal or external jugular vein is selected for insertion.
  • the selected vein is exposed by a standard surgical cutdown procedure.
  • the tapered end of a vein pick is inserted into the incised, selected vein.
  • An introducer is then pushed underneath the vein pick into the vein.
  • the defibrillation catheter is then slid into the introducer and the introducer, with the inserted catheter lead, is then gently fed into the vein.
  • the 6655 9 1 The 6655 9 1
  • introducer is then peeled away and discarded.
  • the catheter is then gently pushed through the vein into the vena cava and thence into the heart, where it is positioned.
  • Defibrillation coils used to deliver the electrical current to defibrillate the heart muscle, are often mounted or integral with other functional elements in defibrillation catheters. These coils are known as transvenous electrodes. One coil generally sits just above the right atrium (RA) in a location within the superior vena cava (SVC). The other coil generally lies within the right ventricle at the right ventricular apex (RVA).
  • RA right atrium
  • SVC superior vena cava
  • RVVA right ventricular apex
  • catheter electrodes are often unable to direct sufficient current through enough of the heart muscle to effect defibrillation. For this reason, a small patch is often inserted just under the skin, on the patient's left side, thus requiring additional, but minimal, surgery.
  • This "subcutaneous patch" is not in direct contact with the heart, but provides for a current vector between the transvenous electrode to the subcutaneous patch, thereby passing through the heart muscle. Thus, the subcutaneous patch assists in directing electric current through the heart muscle, and hence, facilitates defibrillating the heart.
  • the primary barrier to increased utilization of catheter electrodes for defibrillation relates to the ability to successfully lower electrode resistances.
  • the present invention is a cardioversion defibrillation transvenous catheter having at least two electrode coils, each electrode coil having a maximum diameter of less than about 6 French.
  • the electrode coils are longitudinally positioned and coaxial with each other in the catheter.
  • the first electrode coil surrounds a conductor coil for a portion of the catheter length where both the first electrode coil and conductor coil are within a dielectric material and terminates at a first electrode coil not having a dielectric material surrounding the first electrode coil.
  • the second conductor coil extends beyond the first electrode coil where the second conductor coil is within the dielectric material and terminates at the distal end of the catheter, where it is either integral with or bonded to the second electrode coil, which is then wound over the conductor coil.
  • the cardioversion defibrillation transvenous catheter has an exposed length of at least one of the at least two electrode coils which is over 30 times, and preferably over 35 times, the maximum catheter electrode diameter.
  • the cardioversion defibrillation transvenous catheter has an exposed length of at least one of the at least two electrode coils which runs along substantially all of the entire inner distance of an average adult human right ventricle, from the right ventricular apex to the entrance of the right ventricle at the coronary tricuspid valve.
  • the catheter of the present invention may have a single electrode coil, the electrode coil having a maximum diameter of less than about 6 French.
  • the single electrode has an exposed length of the electrode coil which is over 30 times, and preferably over 35 times, the maximum catheter electrode diameter.
  • the cardioversion defibrillation transvenous catheter may have an exposed length of electrode coil which runs along substantially all of the entire inner distance of an average adult human right ventricle, from the right ventricular apex to the entrance of the right ventricle at the tricuspid valve.
  • Figure 1 illustrates a schematic representation of a defibrillating system of the prior art with the pulse generator implanted in the abdominal cavity and epicar dial-patch electrodes attached directly to the heart;
  • Figure 2 illustrates a schematic representation of a defibrillating system of the present invention having a SVC electrode, a RVA electrode and one subcutaneous-patch electrode;
  • Figure 3 illustrates a model for estimation of epicardial patch electrode resistance
  • Figure 4 illustrates a model for estimation of electrical resistance with respect to a cylindrical shell
  • Figure 5 illustrates a plan view of a low profile defibrillation catheter according to the present invention
  • Figure 6 illustrates a cross-sectional view of a low profile defibrillation catheter according to the present invention
  • Figure 7 illustrates a cross-sectional view of a second embodiment of a low profile defibrillation catheter according to the present invention
  • Figure 8 illustrates a cutaway view of the distal portion of a second embodiment of a low profile defibrillation catheter tip showing the attachment of the conductor coil to the electrode coil;
  • Figure 9 illustrates a cutaway view of the distal portion of a second embodiment of a low profile defibrillation catheter tip showing the winding direction of the conductor coil and electrode coil.
  • Figure 10 illustrates a plan view of a single electrode embodiment of the low profile defibrillation catheter according to the present invention.
  • FIG. 1 illustrates a schematic drawing of a patient 10 fitted with a defibrillating system of the prior art consisting of a pulse generator 12 implanted in the abdominal cavity and connected to epicardial-patch electrodes 14 and 16 by electrical-lead harness 18.
  • the placement of epicardial-patch electrodes onto the surface of the heart requires that the surgeon open the chest cavity for placement. This is a much more risky procedure than the procedure required to emplace the present invention.
  • patients in need of defibrillating catheters often are poor candidates for surgical procedures requiring that the chest cavity be opened, thereby precluding them from obtaining the life saving benefits that could otherwise result from inventions of the prior art.
  • Fig. 2 illustrates a schematic drawing of a patient 20 implanted with a defibrillating system of the present invention, including a subcutaneously implanted pulse generator 22 in a subclavian position, a subcutaneous patch electrode 24, and a transvenous catheter 26, carrying a SVC electrode coil 28, and a RVA electrode coil 30.
  • electrode coils 28 and 30 are passed transvenously into the heart chambers usually following the subclavian vein to the superior vena cava and into the heart. Electrode coil 28 sits just above the right heart in the superior vena cava at or near its entrance to the right atrium and coil electrode 30 lies in the right ventricular apex.
  • subcutaneous patch electrode 24 is inserted just under the skin, on the patient's left side. This requires additional, but minimal, surgery. This "subcutaneous patch” is not in direct contact with the heart, but enables a current vector starting at a transvenous electrode to pass through the heart muscle. Thus, subcutaneous patch electrode 24 assists in directing current through the heart muscle, and hence, in defibrillating the heart.
  • the resistance be low enough to provide passage of a sufficiently large current through the heart muscle.
  • the second requirement is that the current field lines pass through the vast majority of the heart muscle. This requirement is usually met by having electrodes of sufficient extent. Thus, the primary opportunity for optimization is in lowering the electrode resistance.
  • the resistance for epicardial patch electrodes can be estimated by using standard formulas from physics and the dimensions of the epicardial patches.
  • a typical impedance for epicardial patches across the heart is:
  • FIG. 4 depicts a catheter electrode of radius, r; length, L; and spaced a distance, R, from a patch electrode, W x W.
  • L and the patch W x W is an infinitesimal volume, V*, with a yet to be determined impedance dZ which can be summed to give an overall impedance Z.
  • This volume V* is situated in a general, but moveable distance r* from the center of the rod and has an infinitesimal thickness (that is,
  • the catheter electrode preferably has a maximum diameter of less than about 6 French (i.e., a maximum diameter ⁇ 2 mm) and an overall length of 30 times, and preferably 35 times, the maximum diameter of the catheter electrode for a multiple electrode configuration.
  • the maximum diameter of the electrode is less than about 6 French and preferably less than about 4 French and the overall length of the electrode is at least 30 times, and preferably at least 35 times, the maximum diameter of the catheter electrode.
  • Figures 5 and 6 illustrate the details of the construction of the present catheter. Note that one of the conductors is wound continuously to the end of the catheter and is then either rewound back over itself to form the actual conductive surface or is electrically bonded to another coil which is wound over the conductor coil.
  • Figure 5 depicts a plan view of visible members of the low profile defibrillation catheter 40 including a junction member 42, electrical connectors 44 and 46 extending from the proximal end of junction member 42, a dielectric flexible plastic tubular member 48 extending from the distal end of junction member 42, a flexible wound electrode coil member 50 extending from the interior of flexible plastic tubular member 48, a flexible dielectric plastic tubular covering 52 having flared ends 54 and 56, of which flared end 54 accommodates the distal end of flexible wound coil electrode member 50, flexible wound electrode coil member 158 extending from the interior of flared end 56 and terminating within tined metal catheter tip 60 at the distal end of flexible wound electrode coil member 158.
  • Connector 44 communicates electrically with flexible wound electrode coil member 50 and connector 46 communicates electrically with flexible wound electrode coil member 158.
  • Flexible wound electrode coil member 50 and conductor coil 58 align coaxially within flexible tubular member 48 and then within flared end member 54 as depicted in Figure 6.
  • Figure 6 depicts a cross-sectional view of the major elements of low profile defibrillation catheter 40.
  • Flexible wound electrode coil 50, flexible plastic tube 62 and flexible wound conductor coil member 58 are arranged in a coaxial fashion extending through flexible tubular member 48 and continuing past the distal end of flexible tubular member 48 to expose flexible wound electrode coil member 50 whose distal end secures and terminates suitably within the confines of flared end 54 of flexible plastic tubular member 52.
  • Flexible wound conductor coil member 58 reverses direction at tined metal catheter tip 60 and is wound back over flexible plastic tube 62 and, ultimately, over itself, thus forming electrode coil 158, which is therefore integral to conductor coil member 58.
  • the flexible wound diameter winding which is aligned within the confines of flexible plastic tube 62, as just described, and a major diameter winding which is aligned over and about the outer periphery of flexible plastic tube 62 and subsequently about itself at a finitely spaced distance. After reversal of direction, the major diameter winding of flexible wound electrode coil member 158 is appropriately terminated between flexible plastic tube 62 and flare 56 of flexible plastic tubular member 52. As depicted in Figure 5, the exposure length of exposed electrode coil wires 50 and 158 is extensive along the length of low profile defibrillation catheter 40.
  • Figures 7, 8 and 9 illustrate the details of the construction of a second embodiment, catheter 140.
  • conductor coil 58 is wound continuously to the end of the catheter and is then electrically and physically connected to electrode coil 158 by crimping or welding or crimping and welding conductor coil 58 to either pin 112 or tube 122 then crimping or welding either pin 112 or tube 122 to electrode coil 158.
  • Figure 7 depicts a cross-sectional view of the major elements of low profile defibrillation catheter 140, a second embodiment of the present invention.
  • Flexible wound electrode coil 50, flexible plastic tube 62 and flexible wound conductor coil member 58 are arranged in a coaxial fashion within flexible tubular member 48 and continue past the distal end of flexible tubular member 48 to expose flexible wound electrode coil member 50 whose distal end secures and terminates suitably within the confines of flared end 54 of flexible plastic tubular member 52.
  • Flexible wound conductor coil member 58 resides coaxially within flexible plastic tube 62.
  • Flexible plastic tube 62 coaxially resides within flexible electrode coil member 158, flexible tubular member 52, or flexible wound electrode coil 50.
  • Flexible wound conductor coil member 58 continues distally, terminating at tined metal catheter tip 60 where it is electrically bonded to flexible wound electrode coil member 158, which is wound in the same direction as flexible wound conductor coil member 58.
  • Flexible wound electrode coil member 158 is appropriately terminated between flexible plastic tube 62 and flare 56 of flexible plastic tubular member 52. As depicted for the first embodiment of this invention in Figure 5, the exposure length of exposed electrode coil wires 50 and 158 is extensive along the length of low profile defibrillation catheter 40.
  • Figure 8 illustrates a cutaway view of the distal tip portion of low profile defibrillation catheter 140, a second embodiment of the present invention, showing the attachment of conductor coil 58 to electrode coil 158 at the distal end of catheter 140.
  • the distal connection consists of conductor coil 58 (shown in Fig. 9), electrode coil 158 and two machined pieces, pin 112 and tube 122, joined by laser welding, resistance welding, crimping, or a combination of these processes.
  • Conductor coil 58 consists of a coiled wire, either unifilar or multifilar, commencing at the proximal end of the lead and terminating at the distal end. It provides a durable, conductive path from the pulse generator to the distal, right ventricular electrode.
  • Electrode coil 158 consists of a coiled wire, round or flat in cross section, commencing at the distal end of the lead and extending proximally for the designated length of the exposed electrode.
  • One machined pin 112 is inserted into the distal end of conductor coil 58 and provides a positive stop for the stylet used for implantation as well as a stop for a crimp joint.
  • the second machined piece is a thin walled tube 122 placed over conductor coil 58. The assembly, conductor coil 58, pin 112 and tube 122 is then crimped.
  • tube 122 may be welded onto conductor coil 58. Tube 122 is then welded to pin 112.
  • electrode coil 158 is then welded, laser or resistance, to tube 122 or pin 112.
  • Alternate constructions to the weld include: (1) welding conductor coil 58 and electrode coil 158 to the surface of pin 112 or tube 122 or (2) welding conductor coil 58 and electrode coil 158 to the end of the pin 112.
  • the conductor and electrode coils may be constructed from any material used for the purpose, including platinum-iridium wire, MP35NTM wire, silver cored MP35NTM wire, or noble metal coated MP35NTM wire (with or without a silver core).
  • Pin 112 and tube 122 can be made of the same material which may be MP35NTM , titanium, or stainless steel.
  • MP35NTM is an alloy comprising nickel, cobalt, chromium and molybdenum and is manufactured by Maryland Specialty Wire Company of Cockeysville, Maryland.
  • This assembly provides a physical and electrical connection that maintains the same diameter as the electrode (i.e. isodiametric), thereby allowing a low profile distal tip of the lead, which aids in insertion of the lead into a vein during implantation. It also allows the conductor coil and the electrode coil to be wound in the same direction ( Figure 9). It also provides a stop for a stylet when placed for introduction of the lead into a vein during implantation.
  • FIG. 10 illustrates a plan view of a single electrode embodiment of the low profile defibrillation catheter 140 according to the present invention.
  • junction member 142 is not bifurcated, connecting electrical connector 44, the only electrical connector necessary, to conductor coil 58.
  • Conductor coil 58 extends from the distal end of junction member 142 terminating within the cavity of tined metal catheter tip 60 as previously described.
  • Conductor coil 58 resides coaxially within flexible plastic tube 62 the entire length of the catheter.
  • Flexible plastic tube 62 resides coaxially within electrode coil 158.
  • Electrode coil 158 is electrically bonded to conductor coil 58 in teh same fashion as depicted and described in the two electrode embodiment of the present invention described above.
  • Electrode coil 158 extends proximally from tined metal catheter tip 60 along a substantial portion of catheter 140 terminating in the distal end of flexible tubular member 48.
  • the distal end of tubular member 48 may also possess a flared end to better provide for securing electrode coil between tubular member 48 and flexible plastic tube 62.
  • the materials used in this single electrode embodiment are identical to those used and described above with respect to the two electrode embodiment with the exception of junction member 142.

Abstract

A low profile defibrillation catheter (40) is disclosed and claimed which is much thinner than existing devices. The thin structure is provided by using the current conductor coil as a first electrode coil (50) and the same materials as the conductor for the second electrode. The distal-most electrode coil (158) is formed by reversing the winding, then winding the electrode coil upon itself, thereby forming an isodiametric catheter. In the second embodiment, the distal-most electrode coil is bonded to the second conductor coil and wound in the same direction, again forming an isodiametric catheter. The thin design is motivated by an electrical field analysis which reveals that the length of the catheter is the important determinant of defibrillation ability, and that the large radius and surface area of prior art devices where not beneficial.

Description

LOW PROFILE DEFIBRILLATION CATHETER
Field of the Invention The present invention pertains to a defibrillation device and, more particularly, refers to a low profile defibrillation catheter where at least one of the current conductors is utilized as a defibrillation electrode.
Background of the Invention The implantable defibrillator requires the use of electrodes to conduct large currents through the human heart. Previously, these electrodes have typically been two or more patches stitched to the heart. These are referred to as epicardial-patch electrodes and require the surgeon to open the chest cavity for placement.
To avoid the surgery required for the epicardial patches, electrode coils are sometimes inserted into the heart chambers via venous routes using various procedures known within the medical and surgical arts. In practice a vein such as the subclavian vein, the right or left cephalic vein or the internal or external jugular vein is selected for insertion. The selected vein is exposed by a standard surgical cutdown procedure. The tapered end of a vein pick is inserted into the incised, selected vein. An introducer is then pushed underneath the vein pick into the vein. The defibrillation catheter is then slid into the introducer and the introducer, with the inserted catheter lead, is then gently fed into the vein. The 6655 9 1
introducer is then peeled away and discarded. Usually using fluoroscopy, the catheter is then gently pushed through the vein into the vena cava and thence into the heart, where it is positioned.
Defibrillation coils, used to deliver the electrical current to defibrillate the heart muscle, are often mounted or integral with other functional elements in defibrillation catheters. These coils are known as transvenous electrodes. One coil generally sits just above the right atrium (RA) in a location within the superior vena cava (SVC). The other coil generally lies within the right ventricle at the right ventricular apex (RVA).
Unfortunately, catheter electrodes are often unable to direct sufficient current through enough of the heart muscle to effect defibrillation. For this reason, a small patch is often inserted just under the skin, on the patient's left side, thus requiring additional, but minimal, surgery. This "subcutaneous patch" is not in direct contact with the heart, but provides for a current vector between the transvenous electrode to the subcutaneous patch, thereby passing through the heart muscle. Thus, the subcutaneous patch assists in directing electric current through the heart muscle, and hence, facilitates defibrillating the heart. There are two primary electrical requirements for defibrillation electrodes. The first is that the resistance be low enough to allow the passage of a large current through the heart. The second requirement is that the current vector passes through the vast majority of the heart muscle. This second requirement is usually met by having sufficient extent to the electrodes and by careful positioning. Thus, other than placement, the primary barrier to increased utilization of catheter electrodes for defibrillation relates to the ability to successfully lower electrode resistances.
The U.S. Patent issued to Kroll et al. (U.S. Patent No. 5,265,623) attempted to more evenly distribute the electrical energy emitted by the claimed electrode during defibrillation by positioning the electrode- conductor connection at or near the mid-point of the electrode. Seeking better defibrillation efficacy by this design, Kroll et al. failed to realize the relative importance of relative electrode dimensions in reducing electrode resistances, other than stating that electrodes with smaller radii generated greater electrical fields. Kroll et al. also taught a preference for electrode lengths of less than 30 times the diameter of the electrode. While Kroll et al. represented an advance in defibrillating catheter technology, the importance of catheter electrode dimensions was neither known nor taught.
Another advance in this field was represented by the teachings of U.S. Patent No. 5,257,634, issued to Kroll. Kroll correctly taught the importance of increased electrode length, but totally failed to address the lesser, but nonetheless substantial importance of catheter diameter. Kroll taught the construction and use of defibrillation electrodes that maximized the effective length of the electrode by employing flexible resilient extension members to the electrode body. While the electrodes of Kroll represented another advance in defibrillator cathode technology, the main purpose was to achieve the maximum possible effective electrode length without the appreciation of some optimum levels or ratios of catheter length and diameter design dimensions. Detailed herein are new physical embodiments of cardioversion defibrillation transvenous catheters with lower electrode resistances. These improved catheters have been enabled by a theoretical discovery which nullifies previous assumptions that maximized electrode surface area or electrode diameter was the most efficient means of constructing catheters with minimum electrode resistances.
Sμmmary pf foe Invention
The present invention is a cardioversion defibrillation transvenous catheter having at least two electrode coils, each electrode coil having a maximum diameter of less than about 6 French. The electrode coils are longitudinally positioned and coaxial with each other in the catheter. The first electrode coil surrounds a conductor coil for a portion of the catheter length where both the first electrode coil and conductor coil are within a dielectric material and terminates at a first electrode coil not having a dielectric material surrounding the first electrode coil. The second conductor coil extends beyond the first electrode coil where the second conductor coil is within the dielectric material and terminates at the distal end of the catheter, where it is either integral with or bonded to the second electrode coil, which is then wound over the conductor coil.
The cardioversion defibrillation transvenous catheter has an exposed length of at least one of the at least two electrode coils which is over 30 times, and preferably over 35 times, the maximum catheter electrode diameter.
The cardioversion defibrillation transvenous catheter has an exposed length of at least one of the at least two electrode coils which runs along substantially all of the entire inner distance of an average adult human right ventricle, from the right ventricular apex to the entrance of the right ventricle at the coronary tricuspid valve.
Alternatively, the catheter of the present invention may have a single electrode coil, the electrode coil having a maximum diameter of less than about 6 French. The single electrode has an exposed length of the electrode coil which is over 30 times, and preferably over 35 times, the maximum catheter electrode diameter. The cardioversion defibrillation transvenous catheter may have an exposed length of electrode coil which runs along substantially all of the entire inner distance of an average adult human right ventricle, from the right ventricular apex to the entrance of the right ventricle at the tricuspid valve.
Brief Description of the Drawings Figure 1 illustrates a schematic representation of a defibrillating system of the prior art with the pulse generator implanted in the abdominal cavity and epicar dial-patch electrodes attached directly to the heart; Figure 2 illustrates a schematic representation of a defibrillating system of the present invention having a SVC electrode, a RVA electrode and one subcutaneous-patch electrode;
Figure 3 illustrates a model for estimation of epicardial patch electrode resistance;
Figure 4 illustrates a model for estimation of electrical resistance with respect to a cylindrical shell;
Figure 5 illustrates a plan view of a low profile defibrillation catheter according to the present invention; Figure 6 illustrates a cross-sectional view of a low profile defibrillation catheter according to the present invention;
Figure 7 illustrates a cross-sectional view of a second embodiment of a low profile defibrillation catheter according to the present invention;
Figure 8 illustrates a cutaway view of the distal portion of a second embodiment of a low profile defibrillation catheter tip showing the attachment of the conductor coil to the electrode coil; and
Figure 9 illustrates a cutaway view of the distal portion of a second embodiment of a low profile defibrillation catheter tip showing the winding direction of the conductor coil and electrode coil. Figure 10 illustrates a plan view of a single electrode embodiment of the low profile defibrillation catheter according to the present invention.
Detailed Description of the Invention Other objects of the present invention and many of the attendant advantages of the present invention will be readily appreciated as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, in which like reference numerals designate like elements throughout the figures. Fig. 1 illustrates a schematic drawing of a patient 10 fitted with a defibrillating system of the prior art consisting of a pulse generator 12 implanted in the abdominal cavity and connected to epicardial-patch electrodes 14 and 16 by electrical-lead harness 18. The placement of epicardial-patch electrodes onto the surface of the heart requires that the surgeon open the chest cavity for placement. This is a much more risky procedure than the procedure required to emplace the present invention. Furthermore, patients in need of defibrillating catheters often are poor candidates for surgical procedures requiring that the chest cavity be opened, thereby precluding them from obtaining the life saving benefits that could otherwise result from inventions of the prior art.
Fig. 2 illustrates a schematic drawing of a patient 20 implanted with a defibrillating system of the present invention, including a subcutaneously implanted pulse generator 22 in a subclavian position, a subcutaneous patch electrode 24, and a transvenous catheter 26, carrying a SVC electrode coil 28, and a RVA electrode coil 30. To avoid the surgery required for emplacing epicardial patches 14 and 16 (Fig. 1), electrode coils 28 and 30 are passed transvenously into the heart chambers usually following the subclavian vein to the superior vena cava and into the heart. Electrode coil 28 sits just above the right heart in the superior vena cava at or near its entrance to the right atrium and coil electrode 30 lies in the right ventricular apex. Unfortunately, catheter-borne electrodes are often unable to direct sufficient current through enough of the heart muscle to effect defibrillation. For this reason, as depicted in Figure 2, a small subcutaneous patch electrode 24 is inserted just under the skin, on the patient's left side. This requires additional, but minimal, surgery. This "subcutaneous patch" is not in direct contact with the heart, but enables a current vector starting at a transvenous electrode to pass through the heart muscle. Thus, subcutaneous patch electrode 24 assists in directing current through the heart muscle, and hence, in defibrillating the heart.
There are two primary electrical requirements for defibrillation electrodes. The first is that the resistance be low enough to provide passage of a sufficiently large current through the heart muscle. The second requirement is that the current field lines pass through the vast majority of the heart muscle. This requirement is usually met by having electrodes of sufficient extent. Thus, the primary opportunity for optimization is in lowering the electrode resistance.
The resistance for epicardial patch electrodes can be estimated by using standard formulas from physics and the dimensions of the epicardial patches. As depicted in Figure 3, the impedance, Z, between two electrodes having surface area, A; separated by distance, d; and having bulk resistivity, p is given by: βd Z = A Eq. 1 and thus, a larger surface area is influential for achieving a low impedance. Typical values for epicardial patch electrodes are A = 30 cm2, d = 7 cm and p = 150 Ω cm. Thus, a typical impedance for epicardial patches across the heart is:
150 * 7 Z = 30 = 35 Ω Eq. 2 which is a value seen in human implants.
When transvenous catheter electrodes were developed it was assumed that a large radius decreased the gap d between the internal catheter borne electrode, and the patch outside the heart. At the same time, a large radius increased the surface area by 2πrl, where r is radius and 1 is length. Thus, designs used diameters that were as large as could be forced into the heart through the often narrow veins. Researchers reported their results with catheter defibrillation using large radius electrodes, typically having a radius of 2 mm and a length of 5 cm.
A close inspection of the situation for a defibrillation catheter implanted in the right ventricle demonstrates that the impedance model of spaced plates in a fluid is inaccurate. A better mode is depicted in Figure 4, which depicts a catheter electrode of radius, r; length, L; and spaced a distance, R, from a patch electrode, W x W. Between L and the patch W x W is an infinitesimal volume, V*, with a yet to be determined impedance dZ which can be summed to give an overall impedance Z. This volume V* is situated in a general, but moveable distance r* from the center of the rod and has an infinitesimal thickness (that is,
"gap") dr*. Careful inspection shows that the arc length would be r*W/R and the height L+r*(W-L)/R and multiplied together would be the "area" referred to in Eq. 1. So multiplying resistivity p by gap dr*, dividing by
"area", and summing (integrating) the infinitesimal volume from r to R, yields:
R f p dr* pR In [1 + Br El Z = J W_ ( W_i ) = WL [1 + BR r ] r r* R (L+ R r*)
W-L Eq. 3
Where B = RL
Substituting typical values into the product Br shows that Br is small, in the range of -0.01 to +0.01, making the numerator in the In function essentially 1. Using 1 instead of 1 + Br, the above equation simplifies to: p_R In (R L )
Z = WL (r W) Eq.4
Substituting typical values into Eq. 4 yields an overall impedance of approximately 100 ohms, which is larger than epicardial patches, but a number very close to that found in clinical tests of transvenous leads.
Upon more rigorous inspection, Eq. 4, reveals that impedance is inversely proportional to L and proportional to the natural logarithm of 1/r. The inverse proportionality to L is what conventional thinking suggests in Eq. 3, but In 1/r entirely changes the situation. Note that the slope of ln(x) is 1/x, meaning that for a large x, the sensitivity to x (that is, the slope of x) has a weak dependence on x when x is large. In the instant case, x = (RL/rW) is indeed large, approximately 50 (R=10 cm; L=8 cm; r=0.2 cm; W=8 cm). The sensitivity to r can be better shown by looking at the percentage change in Z, dZ/Z, as a function of percentage change in r, dr/r.
Mathematically, this is done by taking the differential of Eq. 4 and dividing by Z. One finds: dZ (EL) -1 dr
Z = -In (rw) r . Eq.5
Substituting typical values of R=10, L=8, r=0.2 and W=8, one gets dZ/Z =- 0.16dr/r. The -0.16 factor is very enlightening. It means that a 1% increase in r will decrease impedance only 0.16%, as opposed to L which, because L is inversely proportional to impedance (see Eq. 4) a 1% increase in L would cause a full 1% decrease in impedance. Thus, there results a greater impedance benefit, with the same 2πrL area, for making L as long as possible and r as thin as possible. The more careful analysis done here shows that increasing either L or r will decrease impedance, but that L has a much stronger effect on impedance than does r and, therefore, a long, thin electrode is preferable to a short, thick electrode. In the present invention, the catheter electrode preferably has a maximum diameter of less than about 6 French (i.e., a maximum diameter < 2 mm) and an overall length of 30 times, and preferably 35 times, the maximum diameter of the catheter electrode for a multiple electrode configuration. For a single electrode configuration, the maximum diameter of the electrode is less than about 6 French and preferably less than about 4 French and the overall length of the electrode is at least 30 times, and preferably at least 35 times, the maximum diameter of the catheter electrode.
Figures 5 and 6 illustrate the details of the construction of the present catheter. Note that one of the conductors is wound continuously to the end of the catheter and is then either rewound back over itself to form the actual conductive surface or is electrically bonded to another coil which is wound over the conductor coil.
Figure 5 depicts a plan view of visible members of the low profile defibrillation catheter 40 including a junction member 42, electrical connectors 44 and 46 extending from the proximal end of junction member 42, a dielectric flexible plastic tubular member 48 extending from the distal end of junction member 42, a flexible wound electrode coil member 50 extending from the interior of flexible plastic tubular member 48, a flexible dielectric plastic tubular covering 52 having flared ends 54 and 56, of which flared end 54 accommodates the distal end of flexible wound coil electrode member 50, flexible wound electrode coil member 158 extending from the interior of flared end 56 and terminating within tined metal catheter tip 60 at the distal end of flexible wound electrode coil member 158. Connector 44 communicates electrically with flexible wound electrode coil member 50 and connector 46 communicates electrically with flexible wound electrode coil member 158. Flexible wound electrode coil member 50 and conductor coil 58 align coaxially within flexible tubular member 48 and then within flared end member 54 as depicted in Figure 6. Figure 6 depicts a cross-sectional view of the major elements of low profile defibrillation catheter 40. Flexible wound electrode coil 50, flexible plastic tube 62 and flexible wound conductor coil member 58 are arranged in a coaxial fashion extending through flexible tubular member 48 and continuing past the distal end of flexible tubular member 48 to expose flexible wound electrode coil member 50 whose distal end secures and terminates suitably within the confines of flared end 54 of flexible plastic tubular member 52.
Flexible wound conductor coil member 58 reverses direction at tined metal catheter tip 60 and is wound back over flexible plastic tube 62 and, ultimately, over itself, thus forming electrode coil 158, which is therefore integral to conductor coil member 58. The flexible wound diameter winding which is aligned within the confines of flexible plastic tube 62, as just described, and a major diameter winding which is aligned over and about the outer periphery of flexible plastic tube 62 and subsequently about itself at a finitely spaced distance. After reversal of direction, the major diameter winding of flexible wound electrode coil member 158 is appropriately terminated between flexible plastic tube 62 and flare 56 of flexible plastic tubular member 52. As depicted in Figure 5, the exposure length of exposed electrode coil wires 50 and 158 is extensive along the length of low profile defibrillation catheter 40.
Figures 7, 8 and 9 illustrate the details of the construction of a second embodiment, catheter 140. Note that conductor coil 58 is wound continuously to the end of the catheter and is then electrically and physically connected to electrode coil 158 by crimping or welding or crimping and welding conductor coil 58 to either pin 112 or tube 122 then crimping or welding either pin 112 or tube 122 to electrode coil 158. Figure 7 depicts a cross-sectional view of the major elements of low profile defibrillation catheter 140, a second embodiment of the present invention. Flexible wound electrode coil 50, flexible plastic tube 62 and flexible wound conductor coil member 58 are arranged in a coaxial fashion within flexible tubular member 48 and continue past the distal end of flexible tubular member 48 to expose flexible wound electrode coil member 50 whose distal end secures and terminates suitably within the confines of flared end 54 of flexible plastic tubular member 52.
Flexible wound conductor coil member 58 resides coaxially within flexible plastic tube 62. Flexible plastic tube 62, in turn, coaxially resides within flexible electrode coil member 158, flexible tubular member 52, or flexible wound electrode coil 50. Flexible wound conductor coil member 58 continues distally, terminating at tined metal catheter tip 60 where it is electrically bonded to flexible wound electrode coil member 158, which is wound in the same direction as flexible wound conductor coil member 58. Flexible wound electrode coil member 158 is appropriately terminated between flexible plastic tube 62 and flare 56 of flexible plastic tubular member 52. As depicted for the first embodiment of this invention in Figure 5, the exposure length of exposed electrode coil wires 50 and 158 is extensive along the length of low profile defibrillation catheter 40. Figure 8 illustrates a cutaway view of the distal tip portion of low profile defibrillation catheter 140, a second embodiment of the present invention, showing the attachment of conductor coil 58 to electrode coil 158 at the distal end of catheter 140. The distal connection consists of conductor coil 58 (shown in Fig. 9), electrode coil 158 and two machined pieces, pin 112 and tube 122, joined by laser welding, resistance welding, crimping, or a combination of these processes. Conductor coil 58 consists of a coiled wire, either unifilar or multifilar, commencing at the proximal end of the lead and terminating at the distal end. It provides a durable, conductive path from the pulse generator to the distal, right ventricular electrode. Electrode coil 158 consists of a coiled wire, round or flat in cross section, commencing at the distal end of the lead and extending proximally for the designated length of the exposed electrode. One machined pin 112 is inserted into the distal end of conductor coil 58 and provides a positive stop for the stylet used for implantation as well as a stop for a crimp joint. The second machined piece is a thin walled tube 122 placed over conductor coil 58. The assembly, conductor coil 58, pin 112 and tube 122 is then crimped. As an alternative, tube 122 may be welded onto conductor coil 58. Tube 122 is then welded to pin 112. To finish the electrical connection, electrode coil 158 is then welded, laser or resistance, to tube 122 or pin 112. Alternate constructions to the weld include: (1) welding conductor coil 58 and electrode coil 158 to the surface of pin 112 or tube 122 or (2) welding conductor coil 58 and electrode coil 158 to the end of the pin 112.
The conductor and electrode coils may be constructed from any material used for the purpose, including platinum-iridium wire, MP35N™ wire, silver cored MP35N™ wire, or noble metal coated MP35N™ wire (with or without a silver core). Pin 112 and tube 122 can be made of the same material which may be MP35N™ , titanium, or stainless steel. MP35N™ is an alloy comprising nickel, cobalt, chromium and molybdenum and is manufactured by Maryland Specialty Wire Company of Cockeysville, Maryland. This assembly provides a physical and electrical connection that maintains the same diameter as the electrode (i.e. isodiametric), thereby allowing a low profile distal tip of the lead, which aids in insertion of the lead into a vein during implantation. It also allows the conductor coil and the electrode coil to be wound in the same direction (Figure 9). It also provides a stop for a stylet when placed for introduction of the lead into a vein during implantation.
Figure 10 illustrates a plan view of a single electrode embodiment of the low profile defibrillation catheter 140 according to the present invention. In this single electrode embodiment, junction member 142 is not bifurcated, connecting electrical connector 44, the only electrical connector necessary, to conductor coil 58. Conductor coil 58 extends from the distal end of junction member 142 terminating within the cavity of tined metal catheter tip 60 as previously described. Conductor coil 58 resides coaxially within flexible plastic tube 62 the entire length of the catheter. Flexible plastic tube 62 resides coaxially within electrode coil 158. Electrode coil 158 is electrically bonded to conductor coil 58 in teh same fashion as depicted and described in the two electrode embodiment of the present invention described above. Electrode coil 158 extends proximally from tined metal catheter tip 60 along a substantial portion of catheter 140 terminating in the distal end of flexible tubular member 48. The distal end of tubular member 48 may also possess a flared end to better provide for securing electrode coil between tubular member 48 and flexible plastic tube 62. The materials used in this single electrode embodiment are identical to those used and described above with respect to the two electrode embodiment with the exception of junction member 142.
Changes and modifications in the specifically described embodiments can be carried out without departing from the scope of the invention which is intended to be limited only by the scope of the claims thereof.

Claims

CLAIMSWe claim:
1. A low profile defibrillation catheter (40) having a proximal end (42), a distal end (60) and at least one defibrillation electrode (50) located on an exterior surface of the catheter between the proximal end and the distal end and electrically connected to an electrical connector (44) on the proxfimal end, the low profile defibrillation catheter (40) characterized in that the defibrillation electrode (50) has a maximum diameter of less than about 6 French.
2. A low profile defibrillation catheter (40) having a proximal end (42), a distal end(60), and at least one defibrillation electrode (50) located on an exterior surface of the catheter between the proximal end and the distal end and electrically connected to an electrical connector (44) on the proximal end, the low profile defibrillation electrode characterized in that the defibrillation electrode (50) has a minimum longitudinal length of more than thirty times a maximum diameter of the defibrillation electrode (50).
3. The low profile defibrillation catheter of claim 1 wherein the defibrillation electrode (50) has a longitudinal length that is more than thirty times the maximum diameter.
4. The low profile defibrillation catheter of claim 2 wherein the defibrillation electrode (50) is an electrode coil having a maximum diameter of less than about 6 French.
5. The low profile defibrillation catheter of claims 1 or 2 wherein the catheter includes two defibrillation electrodes (50 158), each defibrillation electrode being an electrode coil having a maximum diameter of less than about 6 French.
6. The low profile defibrillation catheter of claims 1 or 4 wherein the maximum diameter is less than about 4 French.
7. The low profile defibrillation catheter of claims 1 or 2 wherein the defibrillation electrode comprises an electrode coil (158) that is electrically bonded to an underlying, insulated conductor coil (58) electrically connected to the electrical connector (46) at the proximal end, and wherein the electrode coil (158) and the conductor coil (58) are wound in the same direction.
8. The low profile defibrillation catheter of claim 7 wherein the electrode coil (158) and the conductor coil (58) are mechanically and electrically bonded together at a distal end of each.
9. The low profile defibrillation catheter of claim 8 further comprising a cylindrical metallic element (122) coaxial with the distal end of the electrode coil (158) and the conductor coil (58) to which the electrode coil (158) and the conductor coil (58) are mechanically and electrically bonded.
PCT/US1995/010926 1994-08-29 1995-08-29 Low profile defibrillation catheter WO1996006655A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU36252/95A AU3625295A (en) 1994-08-29 1995-08-29 Low profile defibrillation catheter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29821394A 1994-08-29 1994-08-29
US08/298,213 1994-08-29

Publications (1)

Publication Number Publication Date
WO1996006655A1 true WO1996006655A1 (en) 1996-03-07

Family

ID=23149524

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/010926 WO1996006655A1 (en) 1994-08-29 1995-08-29 Low profile defibrillation catheter

Country Status (2)

Country Link
AU (1) AU3625295A (en)
WO (1) WO1996006655A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048887A1 (en) * 1997-04-29 1998-11-05 Medtronic, Inc. Intracardiac defibrillation system
WO2000027471A1 (en) * 1998-11-10 2000-05-18 Intermedics Inc. Cardiac lead with etfe coated dbs coil
WO2000027469A3 (en) * 1998-11-09 2000-08-31 Medtronic Inc Extractable implantable medical lead
US6141593A (en) * 1998-11-10 2000-10-31 Intermedics Inc. Cardiac lead with ETEE coated DBS coil
KR20030040820A (en) * 2001-11-16 2003-05-23 김도균 Trousers
US7239923B1 (en) 2000-08-01 2007-07-03 Cardiac Pacemakers, Inc. Lead having varying stiffness and method of manufacturing thereof
WO2008115383A2 (en) * 2007-03-19 2008-09-25 Boston Scientific Neuromodulation Corporation Methods and apparatus for fabricating leads with conductors and related flexible lead configurations
WO2013066505A1 (en) * 2011-11-04 2013-05-10 Cardiac Pacemakers, Inc. Implantable medical device lead including inner coil reverse-wound relative to shocking coil
US8666508B2 (en) 2008-02-06 2014-03-04 Cardiac Pacemakers, Inc. Lead with MRI compatible design features
US8670840B2 (en) 2006-11-30 2014-03-11 Cardiac Pacemakers, Inc. RF rejecting lead
EP2705874A1 (en) * 2007-03-19 2014-03-12 Boston Scientific Neuromodulation Corporation MRI and RF compatible leads
US8676351B2 (en) 2009-12-31 2014-03-18 Cardiac Pacemakers, Inc. MRI conditionally safe lead with low-profile multi-layer conductor for longitudinal expansion
US8688236B2 (en) 2008-05-09 2014-04-01 Cardiac Pacemakers, Inc. Medical lead coil conductor with spacer element
US8731685B2 (en) 2007-12-06 2014-05-20 Cardiac Pacemakers, Inc. Implantable lead having a variable coil conductor pitch
US8744600B2 (en) 2009-06-26 2014-06-03 Cardiac Pacemakers, Inc. Medical device lead including a unifilar coil with improved torque transmission capacity and reduced MRI heating
US8798767B2 (en) 2009-12-31 2014-08-05 Cardiac Pacemakers, Inc. MRI conditionally safe lead with multi-layer conductor
US8825179B2 (en) 2012-04-20 2014-09-02 Cardiac Pacemakers, Inc. Implantable medical device lead including a unifilar coiled cable
US8825181B2 (en) 2010-08-30 2014-09-02 Cardiac Pacemakers, Inc. Lead conductor with pitch and torque control for MRI conditionally safe use
US8954168B2 (en) 2012-06-01 2015-02-10 Cardiac Pacemakers, Inc. Implantable device lead including a distal electrode assembly with a coiled component
US8958889B2 (en) 2012-08-31 2015-02-17 Cardiac Pacemakers, Inc. MRI compatible lead coil
US8983623B2 (en) 2012-10-18 2015-03-17 Cardiac Pacemakers, Inc. Inductive element for providing MRI compatibility in an implantable medical device lead
US9084883B2 (en) 2009-03-12 2015-07-21 Cardiac Pacemakers, Inc. Thin profile conductor assembly for medical device leads
US9254380B2 (en) 2009-10-19 2016-02-09 Cardiac Pacemakers, Inc. MRI compatible tachycardia lead
US9504821B2 (en) 2014-02-26 2016-11-29 Cardiac Pacemakers, Inc. Construction of an MRI-safe tachycardia lead
US9750944B2 (en) 2009-12-30 2017-09-05 Cardiac Pacemakers, Inc. MRI-conditionally safe medical device lead

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5265623A (en) * 1992-07-16 1993-11-30 Angeion Corporation Optimized field defibrillation catheter

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5265623A (en) * 1992-07-16 1993-11-30 Angeion Corporation Optimized field defibrillation catheter

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048887A1 (en) * 1997-04-29 1998-11-05 Medtronic, Inc. Intracardiac defibrillation system
WO2000027469A3 (en) * 1998-11-09 2000-08-31 Medtronic Inc Extractable implantable medical lead
WO2000027471A1 (en) * 1998-11-10 2000-05-18 Intermedics Inc. Cardiac lead with etfe coated dbs coil
WO2000027470A1 (en) * 1998-11-10 2000-05-18 Intermedics Inc. Cardiac lead with reduced inner crimp sleeve
US6141593A (en) * 1998-11-10 2000-10-31 Intermedics Inc. Cardiac lead with ETEE coated DBS coil
US7239923B1 (en) 2000-08-01 2007-07-03 Cardiac Pacemakers, Inc. Lead having varying stiffness and method of manufacturing thereof
KR20030040820A (en) * 2001-11-16 2003-05-23 김도균 Trousers
US8670840B2 (en) 2006-11-30 2014-03-11 Cardiac Pacemakers, Inc. RF rejecting lead
US9248270B2 (en) 2007-03-19 2016-02-02 Boston Scientific Neuromodulation Corporation Methods and apparatus for fabricating leads with conductors and related flexible
KR101413677B1 (en) 2007-03-19 2014-07-01 엠알아이 인터벤션즈, 인크. Methods and apparatus for fabricating leads with conductors and related flexible lead configurations
US10391307B2 (en) 2007-03-19 2019-08-27 Boston Scientific Neuromodulation Corporation MRI and RF compatible leads and related methods of operating and fabricating leads
WO2008115383A3 (en) * 2007-03-19 2008-12-31 Boston Scient Neuromodulation Methods and apparatus for fabricating leads with conductors and related flexible lead configurations
EP2705874A1 (en) * 2007-03-19 2014-03-12 Boston Scientific Neuromodulation Corporation MRI and RF compatible leads
EP2705875A1 (en) * 2007-03-19 2014-03-12 Boston Scientific Neuromodulation Corporation MRI and RF compatible leads
US9630000B2 (en) 2007-03-19 2017-04-25 Boston Scientific Neuromodulation Corporation Methods and apparatus for fabricating leads with conductors and related flexible lead configurations
US9492651B2 (en) 2007-03-19 2016-11-15 MRI Interventions, Inc. MRI and RF compatible leads and related methods of operating and fabricating leads
WO2008115383A2 (en) * 2007-03-19 2008-09-25 Boston Scientific Neuromodulation Corporation Methods and apparatus for fabricating leads with conductors and related flexible lead configurations
KR101413679B1 (en) 2007-03-19 2014-07-01 보스톤 사이언티픽 뉴로모듈레이션 코포레이션 Mri and rf compatible leads and related methods of operating and fabricating leads
US8731685B2 (en) 2007-12-06 2014-05-20 Cardiac Pacemakers, Inc. Implantable lead having a variable coil conductor pitch
US8666508B2 (en) 2008-02-06 2014-03-04 Cardiac Pacemakers, Inc. Lead with MRI compatible design features
US8688236B2 (en) 2008-05-09 2014-04-01 Cardiac Pacemakers, Inc. Medical lead coil conductor with spacer element
US9084883B2 (en) 2009-03-12 2015-07-21 Cardiac Pacemakers, Inc. Thin profile conductor assembly for medical device leads
US8744600B2 (en) 2009-06-26 2014-06-03 Cardiac Pacemakers, Inc. Medical device lead including a unifilar coil with improved torque transmission capacity and reduced MRI heating
US9254380B2 (en) 2009-10-19 2016-02-09 Cardiac Pacemakers, Inc. MRI compatible tachycardia lead
US9750944B2 (en) 2009-12-30 2017-09-05 Cardiac Pacemakers, Inc. MRI-conditionally safe medical device lead
US8676351B2 (en) 2009-12-31 2014-03-18 Cardiac Pacemakers, Inc. MRI conditionally safe lead with low-profile multi-layer conductor for longitudinal expansion
US8798767B2 (en) 2009-12-31 2014-08-05 Cardiac Pacemakers, Inc. MRI conditionally safe lead with multi-layer conductor
US9050457B2 (en) 2009-12-31 2015-06-09 Cardiac Pacemakers, Inc. MRI conditionally safe lead with low-profile conductor for longitudinal expansion
US9199077B2 (en) 2009-12-31 2015-12-01 Cardiac Pacemakers, Inc. MRI conditionally safe lead with multi-layer conductor
US8825181B2 (en) 2010-08-30 2014-09-02 Cardiac Pacemakers, Inc. Lead conductor with pitch and torque control for MRI conditionally safe use
WO2013066505A1 (en) * 2011-11-04 2013-05-10 Cardiac Pacemakers, Inc. Implantable medical device lead including inner coil reverse-wound relative to shocking coil
US8666512B2 (en) 2011-11-04 2014-03-04 Cardiac Pacemakers, Inc. Implantable medical device lead including inner coil reverse-wound relative to shocking coil
US8825179B2 (en) 2012-04-20 2014-09-02 Cardiac Pacemakers, Inc. Implantable medical device lead including a unifilar coiled cable
US9333344B2 (en) 2012-06-01 2016-05-10 Cardiac Pacemakers, Inc. Implantable device lead including a distal electrode assembly with a coiled component
US8954168B2 (en) 2012-06-01 2015-02-10 Cardiac Pacemakers, Inc. Implantable device lead including a distal electrode assembly with a coiled component
US8958889B2 (en) 2012-08-31 2015-02-17 Cardiac Pacemakers, Inc. MRI compatible lead coil
US8983623B2 (en) 2012-10-18 2015-03-17 Cardiac Pacemakers, Inc. Inductive element for providing MRI compatibility in an implantable medical device lead
US9504822B2 (en) 2012-10-18 2016-11-29 Cardiac Pacemakers, Inc. Inductive element for providing MRI compatibility in an implantable medical device lead
US9504821B2 (en) 2014-02-26 2016-11-29 Cardiac Pacemakers, Inc. Construction of an MRI-safe tachycardia lead
US9682231B2 (en) 2014-02-26 2017-06-20 Cardiac Pacemakers, Inc. Construction of an MRI-safe tachycardia lead

Also Published As

Publication number Publication date
AU3625295A (en) 1996-03-22

Similar Documents

Publication Publication Date Title
US5649974A (en) Low profile defibrillation catheter
WO1996006655A1 (en) Low profile defibrillation catheter
US5044375A (en) Unitary intravascular defibrillating catheter with separate bipolar sensing
EP0428279B1 (en) Braid electrode leads and catheters for using the same
US4481953A (en) Endocardial lead having helically wound ribbon electrode
US5439485A (en) Flexible defibrillation electrode of improved construction
US7711437B1 (en) Lead fixation device
US6968237B2 (en) Implantable coronary sinus lead and lead system
US4355646A (en) Transvenous defibrillating lead
CA2141530C (en) Steroid eluting stitch-in chronic cardiac lead
US6684109B1 (en) Endocardial lead
CA1150775A (en) Trailing tine electrode lead
US5534022A (en) Lead having an integrated defibrillation/sensing electrode
US5342414A (en) Transvenous defibrillation lead
US8688236B2 (en) Medical lead coil conductor with spacer element
CA1323666C (en) Implantable defibrillation electrode
US5488768A (en) Method of forming a defibrillation electrode connection
US20030220676A1 (en) Electrode arrangements for body implantable pacing and sensing leads
EP2044972B1 (en) Implantable medical device lead conductor
US20060293737A1 (en) Multiple electrode implantable lead
JPH0567310B2 (en)
JP2006501028A (en) Cardiac vein lead having a flexible anode and method of manufacturing the same
US5713944A (en) Cardioversion-defibrillation catheter lead having selectively exposable outer conductors
EP2207588B1 (en) Stimulation and sensing lead wtih non-coiled wire construction
US5454839A (en) Low profile defibrillation catheter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA